HIV behind Bars: Human Immunodeficiency Virus Cluster Analysis and Drug Resistance in a Reference Correctional Unit from Southern Brazil

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Prellwitz, Isabel M ^a   Alves, Brunna M ^a   Ikeda, Maria Letícia R ^b,c   Kuhleis, Daniele ^d   Picon, Pedro D ^d   Jarczewski, Carla A ^c   Osório, Marta R ^e   Sánchez, Alexandra ^f,g   Seuánez, Héctor N ^a,h   Larouzé, Bernard ^f,i,j   Soares, Marcelo A ^a,h   Soares, Esmeralda A ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Secretaria de Saúde de Viamão Prefeitura de Viamão   (Brazil)

^c Hosp Sanat Partenon   (Brazil)

^d Governo do Estado do Rio Grande do Sul   (Brazil)

^e Instituto de Pesquisas Biológicas   (Brazil)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g Programa de Controle de Tuberculose   (Brazil)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ INSERM   (France)

^j SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS ZIDOVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; BRAZIL; CIRCULATING INTERSUBTYPE RECOMBINANT FORM; DISEASE TRANSMISSION; EXPOSURE; GENETIC RECOMBINATION; GENOMIC FRAGMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT COMPLIANCE; PRISON; SEROPREVALENCE; STRUCTURAL GENE; UNIQUE RECOMBINANT FORM; VIRUS GENE;

ADULT; ANTI-HIV AGENTS; BRAZIL; CLUSTER ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; PRISONS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879979353     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069033     Document Type: Article

References (43)

1. Baral S, Sifakis F, Cleghorn F, Beyrer C, (2007) Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review. PLoS Med 4: e339.
2. Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, et al. (2012) Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr 59: 185-193.
3. United Nations Office on Drugs and Crime & Joint United Nations Programme on HIV/AIDS (2009) WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organization.
4. United Nations Office on Drugs and Crime & Joint United Nations Programme on HIV/AIDS (2009) Policy Brief: HIV testing and counseling in prison and other closed settings. Geneva: World Health Organization.
5. Dolan K, Kite B, Black E, Aceijas C, Stimson GV, (2007) HIV in prison in low-income and middle-income countries. Lancet Infect Dis 7: 32-41.
6. Coelho HC, Perdona GC, Neves FR, Passos AD, (2007) HIV prevalence and risk factors in a Brazilian penitentiary. Cad Saude Publica 23: 2197-2204.
7. Ministério da Saúde do Brasil (2011) Boletim Epidemiológico Aids e DST In: DST/Aids e Hepatites Virais, editor. Brasília: MInistério da Saúde do Brasil.
8. Burattini M, Massad E, Rozman M, Azevedo R, Carvalho H, (2000) Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Rev Saude Publica 34: 431-436.
9. Cardoso LP, da Silveira AA, Francisco RB, da Guarda Reis MN, Stefani MM, (2011) Molecular characteristics of HIV type 1 infection among prisoners from Central Western Brazil. AIDS Res Hum Retroviruses 27: 1349-1353.
10. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, et al. (2000) HIV-1 nomenclature proposal. Science 288: 55-56.
11. Soares EA, Santos RP, Pellegrini JA, Sprinz E, Tanuri A, et al. (2003) Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. J Acquir Immune Defic Syndr 34: 520-526.
12. Soares EA, Martinez AM, Souza TM, Santos AF, Da Hora V, et al. (2005) HIV-1 subtype C dissemination in southern Brazil. AIDS 19Suppl 4: S81-86.
13. Fontella R, Soares MA, Schrago CG, (2008) On the origin of HIV-1 subtype C in South America. AIDS 22: 2001-2011.
14. Bello G, Passaes CP, Guimaraes ML, Lorete RS, Matos Almeida SE, et al. (2008) Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22: 1993-2000.
15. Bello G, Zanotto PM, Iamarino A, Graf T, Pinto AR, et al. (2012) Phylogeographic analysis of HIV-1 subtype C dissemination in Southern Brazil. PLoS One 7: e35649.
16. Bello G, Soares MA, Schrago CG, (2011) The Use of Bioinformatics for Studying HIV Evolutionary and Epidemiological History in South America. AIDS Res Treat 2011: 154945.
17. Silveira J, Santos AF, Martinez AM, Goes LR, Mendoza-Sassi R, et al. (2012) Heterosexual transmission of human immunodeficiency virus type 1 subtype C in southern Brazil. J Clin Virol 54: 36-41.
18. Santos AF, Lengruber RB, Soares EA, Jere A, Sprinz E, et al. (2008) Conservation patterns of HIV-1 RT connection and RNase H domains: identification of new mutations in NRTI-treated patients. PLoS One 3: e1781.
19. Santos AF, Silveira J, Muniz CP, Tornatore M, Goes LR, et al. (2011) Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naive patients from Southern Brazil. J Clin Virol 52: 373-376.
20. Soares EA, Makamche MF, Siqueira JD, Lumngwena E, Mbuagbaw J, et al. (2010) Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naive Cameroonian subjects with advanced disease. J Clin Virol 48: 173-179.
21. Santos AF, Schrago CG, Martinez AM, Mendoza-Sassi R, Silveira J, et al. (2007) Epidemiologic and evolutionary trends of HIV-1 CRF31_BC-related strains in southern Brazil. J Acquir Immune Defic Syndr 45: 328-333.
22. Hall TA, (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41: 95-98.
23. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, et al. (2010) New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59: 307-321.
24. Keane TM, Creevey CJ, Pentony MM, Naughton TJ, McLnerney JO, (2006) Assessment of methods for amino acid matrix selection and their use on empirical data shows that ad hoc assumptions for choice of matrix are not justified. BMC Evol Biol 6: 29.
25. Anisimova M, Gascuel O, (2006) Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 55: 539-552.
26. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
27. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160.
28. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, et al. (2011) 2011 update of the drug resistance mutations in HIV-1. Top Antivir Med 19: 156-164.
29. Delviks-Frankenberry KA, Nikolenko GN, Maldarelli F, Hase S, Takebe Y, et al. (2009) Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3′-azido-3′-deoxythymidine. J Virol 83: 8502-8513.
30. Delviks-Frankenberry KA, Lengruber RB, Santos AF, Silveira JM, Soares MA,et al. (2012) Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology.
31. Brehm JH, Koontz D, Meteer JD, Pathak V, Sluis-Cremer N, et al. (2007) Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3′-azido-3′-dideoxythymidine. J Virol 81: 7852-7859.
32. Lengruber RB, Delviks-Frankenberry KA, Nikolenko GN, Baumann J, Santos AF, et al. (2011) Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations. J Antimicrob Chemother 66: 702-708.
33. Ehteshami M, Beilhartz GL, Scarth BJ, Tchesnokov EP, McCormick S, et al. (2008) Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3′-azido-3′-deoxythymidine through both RNase H-dependent and-independent mechanisms. J Biol Chem 283: 22222-22232.
34. Tanuma J, Hachiya A, Ishigaki K, Gatanaga H, Lien TT, et al. (2010) Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors. Microbes Infect 12: 1170-1177.
35. Dau B, Ayers D, Singer J, Harrigan PR, Brown S, et al. (2010) Connection domain mutations in treatment-experienced patients in the OPTIMA trial. J Acquir Immune Defic Syndr 54: 160-166.
36. Lopes F, Latorre MR, Campos Pignatari AC, Buchalla CM, (2001) [HIV, HPV, and syphilis prevalence in a women's penitentiary in the city of Sao Paulo, 1997-1998]. Cad Saude Publica 17: 1473-1480.
37. Strazza L, Azevedo RS, Carvalho HB, Massad E, (2004) The vulnerability of Brazilian female prisoners to HIV infection. Braz J Med Biol Res 37: 771-776.
38. Guimaraes T, Granato CF, Varella D, Ferraz ML, Castelo A, et al. (2001) High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis 5: 111-118.
39. Sanchez A, Gerhardt G, Natal S, Capone D, Espinola A, et al. (2005) Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis 9: 633-639.
40. de Medeiros RM, Junqueira DM, Matte MC, Barcellos NT, Chies JA, et al. (2011) Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naive population from Southernmost Brazil: analysis of primary resistance mutations. J Med Virol 83: 1682-1688.
41. Graf T, Passaes CP, Ferreira LG, Grisard EC, Morgado MG, et al. (2011) HIV-1 genetic diversity and drug resistance among treatment naive patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories. J Clin Virol 51: 186-191.
42. Brigido LF, Nunes CC, Oliveira CM, Knoll RK, Ferreira JL, et al. (2007) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. AIDS Res Hum Retroviruses 23: 1579-1586.
43. Passaes CP, Guimaraes ML, Bello G, Morgado MG, (2009) Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil. AIDS Res Hum Retroviruses 25: 1339-1344.